80 related articles for article (PubMed ID: 15095260)
21. Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?
Harari PM; Huang SM
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):976-83. PubMed ID: 14967459
[TBL] [Abstract][Full Text] [Related]
22. Targeted radionuclide therapy in head and neck cancer.
Nestor MV
Head Neck; 2010 May; 32(5):666-78. PubMed ID: 19827126
[TBL] [Abstract][Full Text] [Related]
23. EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.
Cuneo KC; Nyati MK; Ray D; Lawrence TS
Pharmacol Ther; 2015 Oct; 154():67-77. PubMed ID: 26205191
[TBL] [Abstract][Full Text] [Related]
24. [Epidermal growth factor receptor (EGF) in head-and-neck cancers].
Bourhis J; Tao YG; Zhang P; Deutsch E
Bull Cancer; 2007; 94(7 Suppl):F189-91. PubMed ID: 17964995
[TBL] [Abstract][Full Text] [Related]
25. Interaction of EGFR with the tumour microenvironment: implications for radiation treatment.
Nijkamp MM; Span PN; Bussink J; Kaanders JH
Radiother Oncol; 2013 Jul; 108(1):17-23. PubMed ID: 23746695
[TBL] [Abstract][Full Text] [Related]
26. [Molecular basis and clinical results of radiation therapy combined with molecular targeted therapy].
Akimoto T
Nihon Rinsho; 2010 Jun; 68(6):1025-34. PubMed ID: 20535951
[TBL] [Abstract][Full Text] [Related]
27. [Information on head, neck and lung cancers].
Dansin E; Lefebvre JL
Bull Cancer; 2009; 96 Suppl 1():S5-11. PubMed ID: 19433369
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review.
De Felice F; Polimeni A; Valentini V; Brugnoletti O; Cassoni A; Greco A; de Vincentiis M; Tombolini V
Neoplasia; 2018 Mar; 20(3):227-232. PubMed ID: 29448084
[TBL] [Abstract][Full Text] [Related]
29. EGFR-targeting therapy as an evolving concept: learning from nimotuzumab clinical development.
Perez R; Moreno E
Chin Clin Oncol; 2014 Mar; 3(1):5. PubMed ID: 25842083
[TBL] [Abstract][Full Text] [Related]
30. Combining molecular targeted agents with radiation therapy for malignant gliomas.
Scaringi C; Enrici RM; Minniti G
Onco Targets Ther; 2013; 6():1079-95. PubMed ID: 23966794
[TBL] [Abstract][Full Text] [Related]
31. Integrating chemoradiation and molecularly targeted therapy.
Wahl DR; Lawrence TS
Adv Drug Deliv Rev; 2017 Jan; 109():74-83. PubMed ID: 26596559
[TBL] [Abstract][Full Text] [Related]
32. Biotherapeutic Antibodies for the Treatment of Head and Neck Cancer: Current Approaches and Future Considerations of Photothermal Therapies.
Al Qaraghuli MM
Front Oncol; 2020; 10():559596. PubMed ID: 33324546
[TBL] [Abstract][Full Text] [Related]
33. Membrane-Tethered Intracellular Domain of Amphiregulin Promotes Keratinocyte Proliferation.
Stoll SW; Stuart PE; Lambert S; Gandarillas A; Rittié L; Johnston A; Elder JT
J Invest Dermatol; 2016 Feb; 136(2):444-452. PubMed ID: 26802239
[TBL] [Abstract][Full Text] [Related]
34. Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC).
Skvortsov S; Dudás J; Eichberger P; Witsch-Baumgartner M; Loeffler-Ragg J; Pritz C; Schartinger VH; Maier H; Hall J; Debbage P; Riechelmann H; Lukas P; Skvortsova I;
Br J Cancer; 2014 May; 110(11):2677-87. PubMed ID: 24786604
[TBL] [Abstract][Full Text] [Related]
35. Targeted therapy in head and neck cancer.
Kundu SK; Nestor M
Tumour Biol; 2012 Jun; 33(3):707-21. PubMed ID: 22373581
[TBL] [Abstract][Full Text] [Related]
36. Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.
Chung CH; Wong S; Ang KK; Hammond EH; Dicker AP; Harari PM; Le QT
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S67-78. PubMed ID: 17848300
[TBL] [Abstract][Full Text] [Related]
37. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.
Zimmermann M; Zouhair A; Azria D; Ozsahin M
Radiat Oncol; 2006 May; 1():11. PubMed ID: 16722544
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
Raben D; Bianco C; Milas L; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):139-52. PubMed ID: 15095260
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor biology in head and neck cancer.
Kalyankrishna S; Grandis JR
J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281
[TBL] [Abstract][Full Text] [Related]
40. Emerging role of EGFR-targeted therapies and radiation in head and neck cancer.
Song J; Chen C; Raben D
Oncology (Williston Park); 2004 Dec; 18(14):1757-67; discussion 1767, 1771-2, 1777. PubMed ID: 15700625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
